Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi–Goutières syndrome-Reference-Cited by-同舟云学术

Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi–Goutières syndrome

Published:2013-01 Issue:1 Volume:136 Page:245-258
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Cuadrado Eloy,Jansen Machiel H.,Anink Jasper,De Filippis Lidia,Vescovi Angelo L.,Watts Colin,Aronica Eleonora,Hol Elly M.,Kuijpers Taco W.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/136/1/245/13795465/aws321.pdf

Reference59 articles.

1. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis;Aicardi;Ann Neurol,1984

2. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration;Akwa;J Immunol,1998

3. Aicardi-Goutières syndrome: a genetic microangiopathy?;Barth;Acta Neuropathol,1999

4. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection;Berger;PLoS Pathog,2011

5. Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells;Bernal;Aging Cell,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological Impact of Type I Interferon Dysregulation;Rare Neurodegenerative Disorders - New Insights [Working Title];2024-07-31

2. Nanoparticle targeting cGAS-STING signaling in disease therapy;Nano Research;2024-06-15

3. Nucleotide metabolism, leukodystrophies, and CNS pathology;Journal of Inherited Metabolic Disease;2024-02-29

4. Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy;Journal of Clinical Investigation;2024-01-09

5. Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib;Pediatric Rheumatology;2023-10-12